Merkel Cell Carcinoma
Last Posted: May 28, 2021
- A machine-learning modified CART algorithm informs Merkel cell carcinoma prognosis.
Cheraghlou Shayan et al. The Australasian journal of dermatology 2021
- RB1 gene mutations are a distinct predictive factor in Merkel cell carcinoma.
Muto Yusuke, et al. Pathology international 2021 3
- Merkel Cell Polyomavirus in Merkel Cell Carcinoma: Integration Sites and Involvement of the KMT2D Tumor Suppressor Gene.
Arora Reety et al. Viruses 2020 Aug 12(9)
- Circulating Cell-Free miR-375 as Surrogate Marker of Tumor Burden in Merkel Cell Carcinoma.
Fan Kaiji et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 24(23) 5873-5882
- The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy.
Knepper Todd C et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2019 Aug
- FDA Approvals Provide Advances for a Range of Cancer Types
K Honey, AACR Blogs, August 6, 2019
- Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology.
Bichakjian Christopher K et al. Journal of the National Comprehensive Cancer Network : JNCCN 2018 Jun 16(6) 742-774
- New Drugs, New Side Effects: Complications of Cancer Immunotherapy
NCI, May 2019
- Development of predictive models to identify advanced-stage cancer patients in a US healthcare claims database.
Esposito Daina B et al. Cancer epidemiology 2019 May 6130-37
- Poly ADP-ribose polymerase-1 as a potential therapeutic target in Merkel cell carcinoma.
Ferrarotto Renata, et al. Head & neck 2018 3
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.